Copyright Reports & Markets. All rights reserved.

Global Sustained Release Injectables Sales Market Report 2021

Request for Sample of this report
Buy now

1 Sustained Release Injectables Market Overview

  • 1.1 Sustained Release Injectables Product Scope
  • 1.2 Sustained Release Injectables Segment by Type
    • 1.2.1 Global Sustained Release Injectables Sales by Type (2016 & 2021 & 2027)
    • 1.2.2 Naltrexone
    • 1.2.3 Exenatide
    • 1.2.4 Estradiol
    • 1.2.5 Other
  • 1.3 Sustained Release Injectables Segment by Application
    • 1.3.1 Global Sustained Release Injectables Sales Comparison by Application (2016 & 2021 & 2027)
    • 1.3.2 Diabetes
    • 1.3.3 Leukemia
    • 1.3.4 Acromegaly
    • 1.3.5 Other
  • 1.4 Sustained Release Injectables Market Estimates and Forecasts (2016-2027)
    • 1.4.1 Global Sustained Release Injectables Market Size in Value Growth Rate (2016-2027)
    • 1.4.2 Global Sustained Release Injectables Market Size in Volume Growth Rate (2016-2027)
    • 1.4.3 Global Sustained Release Injectables Price Trends (2016-2027)

2 Sustained Release Injectables Estimates and Forecasts by Region

  • 2.1 Global Sustained Release Injectables Market Size by Region: 2016 VS 2021 VS 2027
  • 2.2 Global Sustained Release Injectables Retrospective Market Scenario by Region (2016-2021)
    • 2.2.1 Global Sustained Release Injectables Sales Market Share by Region (2016-2021)
    • 2.2.2 Global Sustained Release Injectables Revenue Market Share by Region (2016-2021)
  • 2.3 Global Sustained Release Injectables Market Estimates and Forecasts by Region (2022-2027)
    • 2.3.1 Global Sustained Release Injectables Sales Estimates and Forecasts by Region (2022-2027)
    • 2.3.2 Global Sustained Release Injectables Revenue Forecast by Region (2022-2027)
  • 2.4 Geographic Market Analysis: Market Facts & Figures
    • 2.4.1 North America Sustained Release Injectables Estimates and Projections (2016-2027)
    • 2.4.2 Europe Sustained Release Injectables Estimates and Projections (2016-2027)
    • 2.4.3 China Sustained Release Injectables Estimates and Projections (2016-2027)
    • 2.4.4 Japan Sustained Release Injectables Estimates and Projections (2016-2027)
    • 2.4.5 Southeast Asia Sustained Release Injectables Estimates and Projections (2016-2027)
    • 2.4.6 India Sustained Release Injectables Estimates and Projections (2016-2027)

3 Global Sustained Release Injectables Competition Landscape by Players

  • 3.1 Global Top Sustained Release Injectables Players by Sales (2016-2021)
  • 3.2 Global Top Sustained Release Injectables Players by Revenue (2016-2021)
  • 3.3 Global Sustained Release Injectables Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sustained Release Injectables as of 2020)
  • 3.4 Global Sustained Release Injectables Average Price by Company (2016-2021)
  • 3.5 Manufacturers Sustained Release Injectables Manufacturing Sites, Area Served, Product Type
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Sustained Release Injectables Market Size by Type

  • 4.1 Global Sustained Release Injectables Historic Market Review by Type (2016-2021)
    • 4.1.1 Global Sustained Release Injectables Sales Market Share by Type (2016-2021)
    • 4.1.2 Global Sustained Release Injectables Revenue Market Share by Type (2016-2021)
    • 4.1.3 Global Sustained Release Injectables Price by Type (2016-2021)
  • 4.2 Global Sustained Release Injectables Market Estimates and Forecasts by Type (2022-2027)
    • 4.2.1 Global Sustained Release Injectables Sales Forecast by Type (2022-2027)
    • 4.2.2 Global Sustained Release Injectables Revenue Forecast by Type (2022-2027)
    • 4.2.3 Global Sustained Release Injectables Price Forecast by Type (2022-2027)

5 Global Sustained Release Injectables Market Size by Application

  • 5.1 Global Sustained Release Injectables Historic Market Review by Application (2016-2021)
    • 5.1.1 Global Sustained Release Injectables Sales Market Share by Application (2016-2021)
    • 5.1.2 Global Sustained Release Injectables Revenue Market Share by Application (2016-2021)
    • 5.1.3 Global Sustained Release Injectables Price by Application (2016-2021)
  • 5.2 Global Sustained Release Injectables Market Estimates and Forecasts by Application (2022-2027)
    • 5.2.1 Global Sustained Release Injectables Sales Forecast by Application (2022-2027)
    • 5.2.2 Global Sustained Release Injectables Revenue Forecast by Application (2022-2027)
    • 5.2.3 Global Sustained Release Injectables Price Forecast by Application (2022-2027)

6 North America Sustained Release Injectables Market Facts & Figures

  • 6.1 North America Sustained Release Injectables Sales by Company
    • 6.1.1 North America Sustained Release Injectables Sales by Company (2016-2021)
    • 6.1.2 North America Sustained Release Injectables Revenue by Company (2016-2021)
  • 6.2 North America Sustained Release Injectables Sales Breakdown by Type
    • 6.2.1 North America Sustained Release Injectables Sales Breakdown by Type (2016-2021)
    • 6.2.2 North America Sustained Release Injectables Sales Breakdown by Type (2022-2027)
  • 6.3 North America Sustained Release Injectables Sales Breakdown by Application
    • 6.3.1 North America Sustained Release Injectables Sales Breakdown by Application (2016-2021)
    • 6.3.2 North America Sustained Release Injectables Sales Breakdown by Application (2022-2027)

7 Europe Sustained Release Injectables Market Facts & Figures

  • 7.1 Europe Sustained Release Injectables Sales by Company
    • 7.1.1 Europe Sustained Release Injectables Sales by Company (2016-2021)
    • 7.1.2 Europe Sustained Release Injectables Revenue by Company (2016-2021)
  • 7.2 Europe Sustained Release Injectables Sales Breakdown by Type
    • 7.2.1 Europe Sustained Release Injectables Sales Breakdown by Type (2016-2021)
    • 7.2.2 Europe Sustained Release Injectables Sales Breakdown by Type (2022-2027)
  • 7.3 Europe Sustained Release Injectables Sales Breakdown by Application
    • 7.3.1 Europe 148 Sales Breakdown by Application (2016-2021)
    • 7.3.2 Europe 148 Sales Breakdown by Application (2022-2027)

8 China Sustained Release Injectables Market Facts & Figures

  • 8.1 China Sustained Release Injectables Sales by Company
    • 8.1.1 China Sustained Release Injectables Sales by Company (2016-2021)
    • 8.1.2 China Sustained Release Injectables Revenue by Company (2016-2021)
  • 8.2 China Sustained Release Injectables Sales Breakdown by Type
    • 8.2.1 China Sustained Release Injectables Sales Breakdown by Type (2016-2021)
    • 8.2.2 China Sustained Release Injectables Sales Breakdown by Type (2022-2027)
  • 8.3 China Sustained Release Injectables Sales Breakdown by Application
    • 8.3.1 China 314 Sales Breakdown by Application (2016-2021)
    • 8.3.2 China 314 Sales Breakdown by Application (2022-2027)

9 Japan Sustained Release Injectables Market Facts & Figures

  • 9.1 Japan Sustained Release Injectables Sales by Company
    • 9.1.1 Japan Sustained Release Injectables Sales by Company (2016-2021)
    • 9.1.2 Japan Sustained Release Injectables Revenue by Company (2016-2021)
  • 9.2 Japan Sustained Release Injectables Sales Breakdown by Type
    • 9.2.1 Japan Sustained Release Injectables Sales Breakdown by Type (2016-2021)
    • 9.2.2 Japan Sustained Release Injectables Sales Breakdown by Type (2022-2027)
  • 9.3 Japan Sustained Release Injectables Sales Breakdown by Application
    • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
    • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Sustained Release Injectables Market Facts & Figures

  • 10.1 Southeast Asia Sustained Release Injectables Sales by Company
    • 10.1.1 Southeast Asia Sustained Release Injectables Sales by Company (2016-2021)
    • 10.1.2 Southeast Asia Sustained Release Injectables Revenue by Company (2016-2021)
  • 10.2 Southeast Asia Sustained Release Injectables Sales Breakdown by Type
    • 10.2.1 Southeast Asia Sustained Release Injectables Sales Breakdown by Type (2016-2021)
    • 10.2.2 Southeast Asia Sustained Release Injectables Sales Breakdown by Type (2022-2027)
  • 10.3 Southeast Asia Sustained Release Injectables Sales Breakdown by Application
    • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
    • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Sustained Release Injectables Market Facts & Figures

  • 11.1 India Sustained Release Injectables Sales by Company
    • 11.1.1 India Sustained Release Injectables Sales by Company (2016-2021)
    • 11.1.2 India Sustained Release Injectables Revenue by Company (2016-2021)
  • 11.2 India Sustained Release Injectables Sales Breakdown by Type
    • 11.2.1 India Sustained Release Injectables Sales Breakdown by Type (2016-2021)
    • 11.2.2 India Sustained Release Injectables Sales Breakdown by Type (2022-2027)
  • 11.3 India Sustained Release Injectables Sales Breakdown by Application
    • 11.3.1 India Sustained Release Injectables Sales Breakdown by Application (2016-2021)
    • 11.3.2 India Sustained Release Injectables Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Sustained Release Injectables Business

  • 12.1 AstraZeneca
    • 12.1.1 AstraZeneca Corporation Information
    • 12.1.2 AstraZeneca Business Overview
    • 12.1.3 AstraZeneca Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
    • 12.1.4 AstraZeneca Sustained Release Injectables Products Offered
    • 12.1.5 AstraZeneca Recent Development
  • 12.2 Eli Lilly
    • 12.2.1 Eli Lilly Corporation Information
    • 12.2.2 Eli Lilly Business Overview
    • 12.2.3 Eli Lilly Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
    • 12.2.4 Eli Lilly Sustained Release Injectables Products Offered
    • 12.2.5 Eli Lilly Recent Development
  • 12.3 Sanofi
    • 12.3.1 Sanofi Corporation Information
    • 12.3.2 Sanofi Business Overview
    • 12.3.3 Sanofi Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
    • 12.3.4 Sanofi Sustained Release Injectables Products Offered
    • 12.3.5 Sanofi Recent Development
  • 12.4 Roche
    • 12.4.1 Roche Corporation Information
    • 12.4.2 Roche Business Overview
    • 12.4.3 Roche Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
    • 12.4.4 Roche Sustained Release Injectables Products Offered
    • 12.4.5 Roche Recent Development
  • 12.5 Novartis
    • 12.5.1 Novartis Corporation Information
    • 12.5.2 Novartis Business Overview
    • 12.5.3 Novartis Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
    • 12.5.4 Novartis Sustained Release Injectables Products Offered
    • 12.5.5 Novartis Recent Development
  • 12.6 Aurobindo
    • 12.6.1 Aurobindo Corporation Information
    • 12.6.2 Aurobindo Business Overview
    • 12.6.3 Aurobindo Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
    • 12.6.4 Aurobindo Sustained Release Injectables Products Offered
    • 12.6.5 Aurobindo Recent Development
  • 12.7 Avadel
    • 12.7.1 Avadel Corporation Information
    • 12.7.2 Avadel Business Overview
    • 12.7.3 Avadel Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
    • 12.7.4 Avadel Sustained Release Injectables Products Offered
    • 12.7.5 Avadel Recent Development
  • 12.8 Biomarin
    • 12.8.1 Biomarin Corporation Information
    • 12.8.2 Biomarin Business Overview
    • 12.8.3 Biomarin Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
    • 12.8.4 Biomarin Sustained Release Injectables Products Offered
    • 12.8.5 Biomarin Recent Development
  • 12.9 Camurus
    • 12.9.1 Camurus Corporation Information
    • 12.9.2 Camurus Business Overview
    • 12.9.3 Camurus Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
    • 12.9.4 Camurus Sustained Release Injectables Products Offered
    • 12.9.5 Camurus Recent Development
  • 12.10 Critical Pharmaceuticals
    • 12.10.1 Critical Pharmaceuticals Corporation Information
    • 12.10.2 Critical Pharmaceuticals Business Overview
    • 12.10.3 Critical Pharmaceuticals Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
    • 12.10.4 Critical Pharmaceuticals Sustained Release Injectables Products Offered
    • 12.10.5 Critical Pharmaceuticals Recent Development
  • 12.11 Alkermes
    • 12.11.1 Alkermes Corporation Information
    • 12.11.2 Alkermes Business Overview
    • 12.11.3 Alkermes Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
    • 12.11.4 Alkermes Sustained Release Injectables Products Offered
    • 12.11.5 Alkermes Recent Development
  • 12.12 Amylin
    • 12.12.1 Amylin Corporation Information
    • 12.12.2 Amylin Business Overview
    • 12.12.3 Amylin Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
    • 12.12.4 Amylin Sustained Release Injectables Products Offered
    • 12.12.5 Amylin Recent Development
  • 12.13 Ascendis Pharma
    • 12.13.1 Ascendis Pharma Corporation Information
    • 12.13.2 Ascendis Pharma Business Overview
    • 12.13.3 Ascendis Pharma Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
    • 12.13.4 Ascendis Pharma Sustained Release Injectables Products Offered
    • 12.13.5 Ascendis Pharma Recent Development
  • 12.14 Taiwan Liposome Company
    • 12.14.1 Taiwan Liposome Company Corporation Information
    • 12.14.2 Taiwan Liposome Company Business Overview
    • 12.14.3 Taiwan Liposome Company Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
    • 12.14.4 Taiwan Liposome Company Sustained Release Injectables Products Offered
    • 12.14.5 Taiwan Liposome Company Recent Development

13 Sustained Release Injectables Manufacturing Cost Analysis

  • 13.1 Sustained Release Injectables Key Raw Materials Analysis
    • 13.1.1 Key Raw Materials
    • 13.1.2 Key Raw Materials Price Trend
    • 13.1.3 Key Suppliers of Raw Materials
  • 13.2 Proportion of Manufacturing Cost Structure
  • 13.3 Manufacturing Process Analysis of Sustained Release Injectables
  • 13.4 Sustained Release Injectables Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

  • 14.1 Marketing Channel
  • 14.2 Sustained Release Injectables Distributors List
  • 14.3 Sustained Release Injectables Customers

15 Market Dynamics

  • 15.1 Sustained Release Injectables Market Trends
  • 15.2 Sustained Release Injectables Drivers
  • 15.3 Sustained Release Injectables Market Challenges
  • 15.4 Sustained Release Injectables Market Restraints

16 Research Findings and Conclusion

    17 Appendix

    • 17.1 Research Methodology
      • 17.1.1 Methodology/Research Approach
      • 17.1.2 Data Source
    • 17.2 Author List

    It is a preparation with better therapeutic effect by delaying drug release rate from the formulation and reducing drug absorption rate into the body.

    Market Analysis and Insights: Global Sustained Release Injectables Market
    The global Sustained Release Injectables market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

    Global Sustained Release Injectables Scope and Market Size
    The global Sustained Release Injectables market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Sustained Release Injectables market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

    Segment by Type
    Naltrexone
    Exenatide
    Estradiol
    Other

    Segment by Application
    Diabetes
    Leukemia
    Acromegaly
    Other

    The Sustained Release Injectables market is analysed and market size information is provided by regions (countries). Segment by Application, the Sustained Release Injectables market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

    By Company
    AstraZeneca
    Eli Lilly
    Sanofi
    Roche
    Novartis
    Aurobindo
    Avadel
    Biomarin
    Camurus
    Critical Pharmaceuticals
    Alkermes
    Amylin
    Ascendis Pharma
    Taiwan Liposome Company

    Buy now